Coagulation disorders and vascular diseases of the liver in patients with COVID-19

The current coronavirus disease 2019 (COVID-19) pandemic has caused a global health emergency crisis, since its outbreak at the end of 2019. Although it mainly affects the respiratory system, it is documented that several important extrapulmonary manifestations exist in the context of the COVID-19 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsafaridou, Maria, Maniadaki, Ilianna, Koutroubakis, Ioannis, Samonakis, Dimitrios N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442661/
https://www.ncbi.nlm.nih.gov/pubmed/36092751
http://dx.doi.org/10.5114/ceh.2022.116972
_version_ 1784782866384683008
author Tsafaridou, Maria
Maniadaki, Ilianna
Koutroubakis, Ioannis
Samonakis, Dimitrios N.
author_facet Tsafaridou, Maria
Maniadaki, Ilianna
Koutroubakis, Ioannis
Samonakis, Dimitrios N.
author_sort Tsafaridou, Maria
collection PubMed
description The current coronavirus disease 2019 (COVID-19) pandemic has caused a global health emergency crisis, since its outbreak at the end of 2019. Although it mainly affects the respiratory system, it is documented that several important extrapulmonary manifestations exist in the context of the COVID-19 infection. Amongst the major pathophysiological mechanisms, the generation of a prothrombotic environment is increasingly recognized and is related to thromboembolic events. We conducted a review of the literature and summarized the coagulation disorders in the liver in patients with COVID-19.
format Online
Article
Text
id pubmed-9442661
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-94426612022-09-09 Coagulation disorders and vascular diseases of the liver in patients with COVID-19 Tsafaridou, Maria Maniadaki, Ilianna Koutroubakis, Ioannis Samonakis, Dimitrios N. Clin Exp Hepatol Review Paper The current coronavirus disease 2019 (COVID-19) pandemic has caused a global health emergency crisis, since its outbreak at the end of 2019. Although it mainly affects the respiratory system, it is documented that several important extrapulmonary manifestations exist in the context of the COVID-19 infection. Amongst the major pathophysiological mechanisms, the generation of a prothrombotic environment is increasingly recognized and is related to thromboembolic events. We conducted a review of the literature and summarized the coagulation disorders in the liver in patients with COVID-19. Termedia Publishing House 2022-06-14 2022-06 /pmc/articles/PMC9442661/ /pubmed/36092751 http://dx.doi.org/10.5114/ceh.2022.116972 Text en Copyright © 2022 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Review Paper
Tsafaridou, Maria
Maniadaki, Ilianna
Koutroubakis, Ioannis
Samonakis, Dimitrios N.
Coagulation disorders and vascular diseases of the liver in patients with COVID-19
title Coagulation disorders and vascular diseases of the liver in patients with COVID-19
title_full Coagulation disorders and vascular diseases of the liver in patients with COVID-19
title_fullStr Coagulation disorders and vascular diseases of the liver in patients with COVID-19
title_full_unstemmed Coagulation disorders and vascular diseases of the liver in patients with COVID-19
title_short Coagulation disorders and vascular diseases of the liver in patients with COVID-19
title_sort coagulation disorders and vascular diseases of the liver in patients with covid-19
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442661/
https://www.ncbi.nlm.nih.gov/pubmed/36092751
http://dx.doi.org/10.5114/ceh.2022.116972
work_keys_str_mv AT tsafaridoumaria coagulationdisordersandvasculardiseasesoftheliverinpatientswithcovid19
AT maniadakiilianna coagulationdisordersandvasculardiseasesoftheliverinpatientswithcovid19
AT koutroubakisioannis coagulationdisordersandvasculardiseasesoftheliverinpatientswithcovid19
AT samonakisdimitriosn coagulationdisordersandvasculardiseasesoftheliverinpatientswithcovid19

Ejemplares similares